![Dollar strengthens ahead of PCE data; euro weighed by political uncertainty](https://i-invdn-com.investing.com/news/LYNXMPEEB40Y1_S.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.470 | 3.510 | 0.040 |
Stocks | 96.470 | 96.470 | 0.000 |
Bonds | 0.040 | 0.040 | 0.000 |
Convertible | 0.020 | 0.020 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.016 | 19.294 |
Price to Book | 3.937 | 3.937 |
Price to Sales | 4.849 | 4.735 |
Price to Cash Flow | 19.794 | 15.513 |
Dividend Yield | 0.290 | 0.501 |
5 Years Earnings Growth | 12.212 | 11.516 |
Number of long holdings: 58
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Amgen | US0311621009 | 6.63 | 312.45 | -0.40% | |
Argen-X | NL0010832176 | 5.10 | 408.60 | -1.87% | |
Blueprint Medicines Corp | US09627Y1091 | 4.56 | 107.78 | -0.68% | |
Vertex | US92532F1003 | 4.16 | 468.72 | -0.80% | |
Zealand Pharma | DK0060257814 | 4.12 | 892.50 | +2.65% | |
Regeneron Pharma | US75886F1075 | 4.04 | 1,051.27 | +0.04% | |
Celldex Therapeutics | US15117B2025 | 3.96 | 37.01 | -1.80% | |
Xenon Pharmaceuticals | CA98420N1050 | 3.63 | 38.99 | +4.22% | |
Rhythm Pharma | US76243J1051 | 3.61 | 41.06 | +2.32% | |
Supernus | US8684591089 | 3.19 | 26.75 | -0.45% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Technology FunD E | 6.99B | 15.47 | 4.46 | 16.64 | ||
Global Technology Fund I E | 6.99B | 15.47 | 5.56 | 17.84 | ||
Global Technology Fund RE | 6.99B | 15.23 | 5.03 | 17.32 | ||
IE00BZ4D7085 | 6.99B | 24.45 | -3.51 | - | ||
IE00BTN23623 | 6.99B | 23.86 | -4.04 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review